Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2009-02-28
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
* To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Small Bioactive Molecules in Early COPD Diseases
NCT04950023
Biomarkers of Chronic Obstructive Pulmonary Disease
NCT04963023
Respiratory Microbiota, Infection Characteristics and Imaging Manifestations in Patients With Chronic Airway Inflammation
NCT06938022
Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)
NCT06685315
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute exacerbation
No interventions assigned to this group
Stable disease
No interventions assigned to this group
Healthy control
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sexes
* Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
* Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
* For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chonbuk National University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonbuk National University Medical School
Jeonju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.